Gyermekkori daganatok: vizsgálatok itt: Szaúd-Arábia
7 of 11 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 4. fázisBefejeződöttAsciminib Roll-over Study
- Where
- Riyadh
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Jeddah, Riyadh
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - 2/3. fázisTaking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Riyadh
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - 3. fázisFelfüggesztveActive Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Where
- Riyadh
- People
- 1780 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03067181 - 2. fázisFelfüggesztveA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Where
- Riyadh
- Életkor
- Up to 30 év
- People
- 256 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04322318 - 3. fázisFelfüggesztveThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Where
- Riyadh
- Életkor
- Up to 50 év
- People
- 62 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05235165 - 3. fázisTaking peopleComparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
- Where
- Riyadh
- Életkor
- 14 év to 65 év
- People
- 264
- Run by
- King Faisal Specialist Hospital & Research Center
See details and how to joinNCT04314219